LivaNova Plc - Company Profile
Powered by 
All the sales intelligence you need on LivaNova Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how LivaNova Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with LivaNova Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on LivaNova Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into LivaNova Plc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
William Kozy
Chairman Executive BoardMr. William Kozy has been the Chairman of the company since 2018. Prior to this, he served as Executive Vice President and Chief Operating Officer; Head of Medical division; President of the Biosciences segment; President of Diagnostics segment; and Senior Vice President of Company Operations for Becton Dickson. He currently serves as the Director of Cooper Companies Inc.
Vladimir A. Makatsaria
Chief Executive Officer; Director Executive BoardMr. Vladimir A. Makatsaria has been the Chief Executive Officer and Director of the company since 2024. Prior to this, he held executive leadership roles at Johnson & Johnson and as Chairman at J&J MedTech; a Member of the global leadership teams for Ethicon, DePuy, and total MedTech. Mr. Makatsaria has also served as Chairman of the Board of the Asia Pacific Medical Technology Association and as an Advisory Board Member to Singapore Management University.
Alex Shvartsburg
Chief Financial Officer Senior ManagementMr. Alex Shvartsburg has been the Chief Financial Officer of the company since 2021. Prior to this, he served as the Vice President of Finance, Strategy & Innovation from September 2017?to?January 2020; Vice President of Corporate Finance and Chief Financial Officer of International Markets from January 2020?to?November 2020; Interim Chief Financial Officer from November 2020 to July 2021. Mr. Shvartsburg also served as Chief Financial Officer and Chief Operating Officer of Caligor Coghlan from June 2016? to September 2017; Vice President of Finance Genetic Science Division at Thermo Fisher Scientific from January 2014?to?June 2016; and Senior Finance Director of Mergers & Acquisitions with Life Technologies from June 2012?to?January 2014.
Michael Hutchinson
Senior Vice President; Chief Legal Officer; Secretary Senior ManagementMr. Michael Hutchinson has been the Chief Legal Officer, Secretary, and Senior Vice President of the company since 2022. Prior to this, he served as the Senior Vice President, Chief Legal Officer and Corporate Secretary at ByHeart Inc. Mr. Hutchinson has also served as the Senior Vice President and General Counsel at Varian Medical Systems.
Ahmet Tezel
Chief Innovation Officer Senior ManagementMr. Ahmet Tezel has been the Chief Innovation Officer of the company since 2024. Prior to this, he served on the global R&D and innovation teams at Johnson & Johnson MedTech. Mr. Tezel has also served in R&D roles at healthcare companies, including Ethicon, Alcon, and Allergan, developing Class III implantable and complex capital equipment.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer